Dyee Capital
Dyee Capital is an investment firm.
Business Model:
Revenue: $0
Employees: 0-0
Rankings
Industries / Tags:
Detailed Dyee Capital Information
Geographic Data
Address:
City:
State:
Zip:
Country:
Financial Info
Stage:
Raised Last:
$0
Raised Total:$0
Social
Crunchbase
Metrics
0Website Global Rank
0Website Monthly Traffic
Twitter Followers
Description
Dyee Capital is an investment firm.
Contact Phone:
Contact Email:
| Announced Date | Company | Transaction | Money Raised |
|---|---|---|---|
| 10/2021 | Leads Biolabs | Series C | 0 |
| 10/2017 | A1Food | Series A | - |
| 6/2017 | Xiao Qu Hao Hushi | Series A | 9.4M |
| 7/2022 | BridGene Biosciences | Series B | 0 |
| 5/2021 | Phanes Therapeutics | Series B | 0 |
| 9/2019 | A1Food | Series B | 14M |
| 12/2019 | Elpiscience Biopharmaceuticals | Series B | 0 |
| 11/2022 | Beijing Weilan New Energy Technology | Series D | 206.5M |
| 5/2018 | FineEx | Series C | 58M |
| 6/2022 | Degron Therapeutics | Series A | 0 |
| 8/2020 | LP Pharmaceuticals | Series C | 72M |
| 6/2018 | Zongmu | Series C | - |
| 1/2023 | Genepoint Biological Technology | Series D | 29.5M |
| 8/2021 | Ionova Life Science | Private Equity Round | 100M |
| 4/2018 | Borns Robot | Series A | 15.8M |
| 4/2021 | SceneRay | Series D | - |
| 1/2022 | Cloudbreak Therapeutics | Series C | 0 |
| 10/2019 | Ionova Life Science | Series A | 17.8M |
| 1/2021 | Maxi Novel | Series C | 30.9M |
| 5/2019 | Allist Pharmaceuticals | Series A | 173.9M |
| 12/2016 | Weijiechengpei | Series A | - |
| 5/2022 | Microclear | Series C | - |
| 3/2021 | FutureGen | Series B | 46.1M |
| 6/2018 | Weijiechengpei | Series B | 18M |
| 9/2020 | InventisBio | Series D | 0 |
| 12/2021 | GenFleet Therapeutics | Series C | 0 |
| 1/2021 | Ark Biosciences | Series C | 86k |
| 3/2018 | KTVme | Series B | 19.1M |
| 11/2022 | ininin.com | Venture Round | - |
| 11/2021 | Zhimeng Biopharma | Series B | 0 |
| 5/2021 | Elpiscience Biopharmaceuticals | Series C | 0 |
| 1/2019 | Hebaodan | Seed Round | 3M |
| 8/2016 | meet you | Series E | 150.7M |
| 7/2022 | BridGene Biosciences | Series B | 0 |
| 6/2022 | Degron Therapeutics | Series A | 0 |
| 5/2022 | Microclear | Series C | - |
| 1/2022 | Cloudbreak Therapeutics | Series C | 0 |
| 12/2021 | GenFleet Therapeutics | Series C | 0 |
| 11/2021 | Zhimeng Biopharma | Series B | 0 |
| 10/2021 | Leads Biolabs | Series C | 0 |
| 8/2021 | Ionova Life Science | Venture Round | 0 |
| 5/2021 | Elpiscience Biopharmaceuticals | Series C | 0 |
| 5/2021 | Phanes Therapeutics | Series B | 0 |
Startup Industries
Startup Locations
Portfolio Current Status
Portfolio Employee Count
| Name | Price |
|---|
| Name | Size | Announced Date |
|---|
